GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Retail - Cyclical » Trilogy AI Corp (OTCPK:TRAIF) » Definitions » Loans Receivable

TRAIF (Trilogy AI) Loans Receivable : $0.00 Mil (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Trilogy AI Loans Receivable?

Trilogy AI's Loans Receivable for the quarter that ended in Sep. 2024 was $0.00 Mil.

Trilogy AI's annual Loans Receivable declined from Dec. 2021 ($0.32 Mil) to Dec. 2022 ($0.00 Mil) but then stayed the same from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.00 Mil).


Trilogy AI Loans Receivable Historical Data

The historical data trend for Trilogy AI's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trilogy AI Loans Receivable Chart

Trilogy AI Annual Data
Trend Dec21 Dec22 Dec23
Loans Receivable
0.32 - -

Trilogy AI Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Trilogy AI Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Trilogy AI Loans Receivable Related Terms

Thank you for viewing the detailed overview of Trilogy AI's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Trilogy AI Business Description

Traded in Other Exchanges
Address
905 West Pender Street, 6th Floor, Vancouver, BC, CAN, V6C 1L6
Trilogy AI Corp formerly Ambari Brands Incy is an emerging cosmetic company. It is a luxury skincare and consumer packaged goods company and has developed a product line on its proprietary Modern Blend. It generates revenue from the sale of skincare products directly to consumers and luxury department stores, and on a wholesale basis to distributors and spas.